SPEAKERS

 

 

The 2017 line-up includes speakers from World Veterinary Vaccine Congress, World Vaccine Congress Europe and the Immune Profiling World Congress.

Kunal Aggarwal, Head of Technical R&D Programs - R&D Center USA, GSK Vaccines

Kunal Aggarwal at World Veterinary Vaccine Congress

Dr Osama Ahmed Hassan Ahmed, Infectious Diseases Epidemiologist, Umea University

Prof Jeffrey Almond, Former Vice President Discovery Research and Development, Sanofi and Visiting Professor, University of Oxford - Oxford Vaccine Group

Dr Marisa Arias Neira, Technical Director, Instituto Nacional De Investigacion Agraria Y Alimentaria

Dr Philip Arlen, President and Chief Executive Officer, Precision Biologics Inc

Dr Florence Arvis, Head of Formulation Unit, Sanofi Pasteur Sa

Dr Jean-Christophe Audonnet, Senior Director, Research Strategy and Key Alliances, Bio R&D and Coordinatior at ZAPI, Merial

Dr Jean-Christophe Audonnet, Senior Director, Research Strategy and Key Alliances, Bio R&D and Coordinatior at ZAPI, Merial

Dr Arnaud Bataille, Researcher in Virology, C.I.R.A.D.

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories (MSD)

Dr Norman Begg, Vice President, Head of Scientific Affairs and Public Health, GSK Vaccines

Prof Sumi Biswas, Associate Professor, University of Oxford

Dr Anissa Boumlic-Courtade, Vaccine Market Lead, EMEA, MERCK

Dr Jo Brewer, VP Platform Science, Adaptimmune

Dr James Brooks, Research and Development Manager, BD Biosciences

Dr Rosario Bullido, Head of Veterinary Inmunological Medicines Assessment Unit Veterinary Medicines Department, Aemps

Dr Rosario Bullido at World Veterinary Vaccine Congress

Dr Trent Carrier, Vice President - Vaccine Technology and Engineering, Takeda

Miles Carroll, Deputy Director, Public Health England

Francesca Ceddia, VP, Head Global Medical Affairs Vaccines, GSK Vaccines

Dr Brian Champion, CSO, Psioxus Therapeutics

Dr Brian Champion at World Veterinary Vaccine Congress

Dr Brian Champion, CSO, Psioxus Therapeutics

Nathalie Charland, Sr Dir. Scientific & Medical Affairs, Medicago Inc

Catherine Charreyre, Head of Research Projects, Merial

Anne Chevrel, Research and Development Project Manager, Affilogic

Anne Chevrel at World Veterinary Vaccine Congress

Trevor Clancy, Co Founder and Chief Scientific Officer, OncoImmunity

Gillian Cowan, Regulatory Affairs Consultant, Global Alliance For Livestock Veterinary Medicines

Dr Sandrine Crabe, Research & Development Director, ABIVAX

Dr James Cummings, Vice President, Clinical Development and Translational Medicine, Novavax

Dr James Cummings at World Veterinary Vaccine Congress

Nandakumar D Reddy, Director Global Vaccine Research, Elanco Animal Health

Nandakumar D Reddy at World Veterinary Vaccine Congress

Prof Ron Dagan, head, pediatric Infectious diseases, Ben Gurion University

Angus Dalgleish, Foundation Chair in Clinical Oncology + Research Director, St George's University, London

Angus Dalgleish, Foundation Chair in Clinical Oncology + Research Director, St George's University, London

Dr Peter Daszak, President, Ecohealth Alliance Inc.

Dr Kris De Clercq, Head of Unit, CODA CERVA (Veterinary and Agrochemical Research Centre)

Jean de Foucauld, Senior Bio Regulatory Expert, Ceva Santé Animale

Dr Tanja De Gruijl, Professor of Translational Tumor Immunology, Vumc Cancer Center

Rob Dekker, CMC Team Lead, Janssen Infectious Diseases and Vaccines

Antu Dey, Senior Director, Research & Development, International AIDS Vaccine Initiative

Dr Joseph Domenech, Consultant, ex World Animal Health Organization (OIE) Chargé de Mission and FAO Head of Animal Head Service, O.I.E.

Dr Joseph Domenech, Consultant, ex World Animal Health Organization (OIE) Chargé de Mission and FAO Head of Animal Head Service, O.I.E.

Dr Tom Dubensky, Chief Scientific Officer, Aduro BioTech Inc

Dr Bernd Eisele, Chief Executive Officer, Vakzine Projekt Management Gmbh

Dr Krishna M Ella, Founder and Chairman, Bharat Biotech International Ltd

Dr Katie Ewer, PI, Senior Immunologist-Malaria and Ebola Vaccine Trials, University of Oxford

Dr Katie Ewer at World Veterinary Vaccine Congress

Amir Faridmoayer, Co-Founder & Vice President Discovery, LimmaTech Biologics AG

Prof Farzin Farzaneh, Professor of Molecular Medicine, King's College Hospital NHS Trust

Prof Farzin Farzaneh at World Veterinary Vaccine Congress

Dr Sylvain Fleury, Chief Scientific Officer, Mymetics Corporation Sa

Dr Patrick Frayssinet, R&D Director, URODELIA

Dr Martin Friede, Coordinator, Initiative for Vaccine Research Immunization, Vaccines and Biologicals Department, WHO

Bradley Garcia, Strategic Technology Commercialization Leader, Roche Sequencing Solutions

Bradley Garcia at World Veterinary Vaccine Congress

Dr Nathalie Garcon, CEO/CSO, BIOASTER

Dr Nathalie Garcon, CEO/CSO, BIOASTER

Glen Gifford, Chargé de mission, Oie (World Organisation For Animal Health)

Dr Gregory Glenn, President, Research and Development, Novavax

Dr Gregory Glenn at World Veterinary Vaccine Congress

Prof David Goldblatt, Professor of Vaccinology and Immunology and Director of Clinical Research and Development, UCL

Dr Farshad Guirakhoo, CSO, GeoVax, Inc.

Dr Farshad Guirakhoo at World Veterinary Vaccine Congress

Dr Bart Haagmans, Working Group Leader, Department of Viroscience and Co-coordinator at ZAPI, Erasmus M.C.

Dr Bart Haagmans, Working Group Leader, Department of Viroscience and Co-coordinator at ZAPI, Erasmus M.C.

Dr Ali M. Harandi, Lab head, Dpt of Microbiology & Immunology, University of Gothenburg

Dr Vanessa Harris, Amsterdam Institute for Global Health and Development, University of Amsterdam

Richard Hatchett, CEO, CEPI

Ingmar Hoerr, Chief Executive Officer, Paul Ehrlich Curevac GmbH

Marc Hoffman, CMO, Celerion

Henrik Hornsved, Senior Business Development, West Pharmaceutical Services Danmark As

Dr Suresh Jadhav, Executive Director, Serum Institute of India

Prof Stephen Albert Johnston, Director, Biodesign Institute at Arizona State University

Dr Stephen Albert Johnston, Director, Biodesign Institute at Arizona State University

Dr Rik Koopman, Global Technical Director, MSD Animal Health

Alexander Kort, Head Of Business Processes & Quality, Themis Bioscience GmbH

Dr Willem-Jan Krebber, Director of Operations, I.S.A. Therapeutics Bv

Dr Willem-Jan Krebber, Director of Operations, I.S.A. Therapeutics Bv

Dr David Krige, Head of Biomarkers, Immunocore Limited

Dr David Krige at World Veterinary Vaccine Congress

Dr Mahesh Kumar, Vice President, Global Biologics Research, Zoetis

Dr Jean Lang, Associate Vice President, R&D Projects Global Health, Partnerships & Funding, Sanofi Pasteur

Dr Hans Langedijk, Director of Subunit Vaccine Design, Janssen Vaccines & Prevention B.V.

Yves Leurquin, Head of Vaccine Market Access, Takeda Pharmaceuticals International Ag

Yotam Levin, Chief Executive Officer, NanoPass Technologies

Bernhard Liegl, VP Global Clinical Development, Celerion

Dr Stephen Lockhart, Vice President and Head of Europe and Asia-Pacific Vaccine Clinical Research and Development (VCRD), Pfizer

Patricia Londono-Hayes, Sr. Director / Head R&D Initiatives, Europe, Sanofi

Patricia Londono-Hayes at World Veterinary Vaccine Congress

Alfred Luitjens, Director Cell Technology at Batavia Biosciences, Batavia Biosciences

Dr Michael Makanga, Executive Director, European and Developing Countries Clinical Trials Partnership

Dr Anna-Karin Maltais, Chief Scientific Officer, Eurocine Vaccines AB

Dr Adrian McDermott, Chief, Immunology Core, Vaccine Research Center, NIAID

Phillipe Migraine, Director Regulatory Affairs, Merial

Phillipe Migraine at World Veterinary Vaccine Congress

Dr Jacqueline Miller, VP Clinical R&D, GSK Biologicals

Dr Philip Minor, Former Deputy Director, Head of Virology, NIBSC & Member of the WHO Advisory Panel on Biological Standardization, National Institute for Biological Standards and Control

Dr Richard Mole, Commercialisation Manager, Moredun Institute

Dr Richard Mole at World Veterinary Vaccine Congress

Prof Emanuele Montomoli, Prof in Public Health University of Siena & CSO, VisMederi

Paul Moore, Vice President, Cell Biology & Immunology, Macro Genics Inc

Dr Dafne Mueller, Group Leader, Institute of Cell Biology and Immunology, University of Stuttgart

Salim Mujais, Senior Vice President of Therapeutic Area Head, Immunology. Transplant, Infectious Disease, CNS & Pain, Astellas Pharma Inc

Salim Mujais at World Veterinary Vaccine Congress

Salim Mujais, Senior Vice President of Therapeutic Area Head, Immunology. Transplant, Infectious Disease, CNS & Pain, Astellas Pharma Inc

Salim Mujais at World Veterinary Vaccine Congress

Dr Eszter Nagy, Co-Founder, President and CSO, Arsanis Inc

Dr Charles Nicolette, Chief Scientific Officer, Argos Therapeutics

Dr Charles Nicolette, Chief Scientific Officer, Argos Therapeutics

Dr Charles Nicolette at World Veterinary Vaccine Congress

Dr Marta Nunes, Senior Scientist, University of the Witwatersrand

Prof Albert Osterhaus, Director Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover

Prof Ab Osterhaus, Director, Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover

Dr Marie Paule Kieny, Assistant Director General, World Health Organization

Dr Nikolai Petrovsky, Chairman, Vaxine Pty.

Dr Nikolai Petrovsky, Chairman, Vaxine Pty.

Dr Nikolai Petrovsky, Chairman, Vaxine Pty.

Dr Kai Pinkernell, Chief Medical Officer & Senior Vice President of Medical Affairs, Medigene Ag

Ivo Ploemen, Program Manager, Intravacc

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Jan Poolman, Head Bacterial Vaccine Discovery and Early Development, Janssen

Christophe Queva, Chief Scientific Officer, Iteos Therapeutics

Dr K Vijay Raghavan, Secretary, Department of Biotechnology Ministry of Science and Technology, Government of India

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines

Dr Sai Reddy, Assistant Professor of Bimolecular Engineering, E.T.H. Zurich

Zarifah Reed, Medical Director, Sentinext Therapeutics

Zarifah Reed at World Veterinary Vaccine Congress

Dr Steven Reed, President, Founder & CEO, Infectious Disease Research Institute

Prof Helen Rees, Chair and Executive Director, Wits Reproductive Health and HIV Institute

Jeff Riley, Chief Executive Officer, President and Director, Synthetic Biologics Inc

Dr Laura Rosa Brunet, Chief Scientific Officer, Immodulon Therapeutics Ltd

Prof Stephen Russell, Professor of Medicine, Mayo Clinic

Armin Saalmueller, Professor, University of Veterinary Medicine

Armin Saalmueller at World Veterinary Vaccine Congress

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Nathaly Samy, Senior Vice President - Clinical Development, Bavarian Nordic

Dr Melanie Saville, VP, Head of Late Development, Clinical and Medical Affairs, Janssen Vaccines & Prevention B.V.

Dr Emmett Schmidt, Executive Director, Clinical Research, Merck Research Laboratories - Oncology, Merck & Co.

Dr Ruprecht Schmidt Ott, European Director for Scientific Affairs & Public Health, GSK Vaccines

Dr Randolph Seidler, Head of Global Business Development AH, Boehringer Ingelheim Animal Health Gmbh

Hui (David) Shao, Chief Financial Officer, Yisheng Biopharma

Dr Vivek Shinde, Director of Clinical Development Lead, Pediatric and Older Adult Rsv Vaccines, Novavax

Dr Maja Sommerfelt, Chief Scientific Officer, Bionor Immuno AS

Bruno Speder, Head of Clinical Regulatory Affairs, S.G.S. Life Science Services

Gregory Stoloff, Chief Executive Officer, Seek

Dr Artur Summerfield, Proffesor of Immunology, Group Head, Institute of Virology and Immunology

Prof Adel Talaat, Professor of Microbiology, University of Wisconsin-Madison

Dr Adel Talaat, Professor of Microbiology, University of Wisconsin-Madison

Dr John Tan, Senior Scientist, Technology Innovation, Roche Sequencing Solutions

Dr Frédéric Tangy, Director of R&D, CNRS, Institut Pasteur

Dr Peter Timmerman, Chief Scientific Officer, Pepscan Therapeutics

Dr Peter Timmerman at World Veterinary Vaccine Congress

Dr Peter Timmerman, Chief Scientific Officer, Pepscan Therapeutics

Dr Sean Tucker, CSO and VP Research, Vaxart

Dr Alicia Urniza, Director EU Biologicals, VMRD, Zoetis

Dr Bernard Vallat, Honorary Director General, Office International Des Epizooties

Dr Carel van Baalen, Director R&D, Viroclinics Biosciences

Dr Marcelle Van Mechelen, Senior Scientific Advisor, Caprion

Prof Martin Vordermeier, Team Leader, Animal Health and Veterinary Laboratories Agency

Prof Martin Vordermeier, Team Leader, Animal Health and Veterinary Laboratories Agency

Dr Jun Wang, Cancer Immunotherapy, Product Development Oncology, Cancer Immunotherapy Franchise, Genentech

Dr Jun Wang at World Veterinary Vaccine Congress

Dr Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services

Yariv Wine, Senior Lecturer, Tel Aviv University

Dr Vidadi Yusibov, Executive Director, Fraunhofer Center for Molecular Biotechnology